hydralazine has been researched along with Reperfusion Injury in 5 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydralazine has shown renoprotective effects in multiple kidney diseases and was shown to be a potent xanthine oxidase (XO) inhibitor." | 5.91 | Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease. ( Chang, TT; Chen, C; Chen, JW; Chiang, CH; Fang, SY; Lin, SC, 2023) |
| "Hydralazine has shown renoprotective effects in multiple kidney diseases and was shown to be a potent xanthine oxidase (XO) inhibitor." | 1.91 | Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease. ( Chang, TT; Chen, C; Chen, JW; Chiang, CH; Fang, SY; Lin, SC, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leu, JG | 1 |
| Su, WH | 1 |
| Chen, YC | 1 |
| Liang, YJ | 1 |
| Chiang, CH | 1 |
| Chen, C | 1 |
| Fang, SY | 1 |
| Lin, SC | 1 |
| Chen, JW | 1 |
| Chang, TT | 1 |
| Li, Y | 1 |
| Hou, D | 1 |
| Chen, X | 1 |
| Zhu, J | 1 |
| Zhang, R | 1 |
| Sun, W | 1 |
| Li, P | 1 |
| Tian, Y | 1 |
| Kong, X | 1 |
| Tampe, B | 1 |
| Steinle, U | 1 |
| Tampe, D | 1 |
| Carstens, JL | 1 |
| Korsten, P | 1 |
| Zeisberg, EM | 1 |
| Müller, GA | 1 |
| Kalluri, R | 1 |
| Zeisberg, M | 1 |
| Bhabra, MS | 1 |
| Hopkinson, DN | 1 |
| Shaw, TE | 1 |
| Hooper, TL | 1 |
5 other studies available for hydralazine and Reperfusion Injury
| Article | Year |
|---|---|
Hydralazine attenuates renal inflammation in diabetic rats with ischemia/reperfusion acute kidney injury.
Topics: Acute Kidney Injury; Animals; Cells, Cultured; Coculture Techniques; Diabetes Mellitus, Experimental | 2021 |
Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
Topics: Acute Kidney Injury; Animals; Enzyme Inhibitors; Fibrosis; Humans; Hydralazine; Inflammation; Kidney | 2023 |
Hydralazine protects against renal ischemia-reperfusion injury in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cytokines; Hydralazine; Kidney; Male; | 2019 |
Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Animals; CpG Islands; Dioxygenases; D | 2017 |
Attenuation of lung graft reperfusion injury by a nitric oxide donor.
Topics: Animals; Cardioplegic Solutions; Disease Models, Animal; Disease Progression; Hemodynamics; Hydralaz | 1997 |